CAIMAN validates AI prescreening of typical and atypical large-bowel biopsies across UK and Portuguese cohorts
CAIMAN is a weakly supervised deep-learning model trained on pathologist-labeled whole-slide images to classify typical, atypical non-neoplastic and atypical neoplastic bowel biopsies. In three external cohorts comprising 1,536 slides from the UK and Portugal, it detected atypical biopsies with AUROC values of 0.9431, 0.9576 and 0.9636. At 99% sensitivity, it outperformed the prior IDaRS pipeline on two external cohorts, but not the third.
Technology: CAIMAN (Colorectal AI Model for Abnormality Detection), a weakly supervised deep-learning whole-slide image classifier
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: In three external cohorts comprising 1,536 slides from the UK and Portugal, it detected atypical biopsies with AUROC values of 0.9431, 0.9576 and 0.9636.
- Still unknown: Retrospective validation on archived biopsies does not establish clinical deployment or improved patient outcomes. CAIMAN did not outperform IDaRS at 99% sensitivity in one of the three external validation cohorts; the authors call for larger multicentre validation and a clinical trial. The reported 99% sensitivity is paired with cohort-specific specificity, not a universal performance guarantee.
- AI role: AI learned biopsy-level histological patterns from slide-level diagnostic labels, then classified whole-slide images into typical, atypical non-neoplastic or atypical neoplastic classes. The trained frozen model was evaluated on three external cohorts; the reported finding is a specific retrospective clinical diagnostic-validation result.
Evidence sources: https://wrap.warwick.ac.uk/id/eprint/180883/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 50 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.